Truist Financial’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$614K Sell
74,033
-145,419
-66% -$1.51M ﹤0.01% 1956
2025
Q4
$2.71M Sell
219,452
-49,842
-19% -$534K ﹤0.01% 1128
2025
Q3
$2.38M Sell
269,294
-92,743
-26% -$721K ﹤0.01% 1250
2025
Q2
$2.31M Buy
362,037
+26,608
+8% +$152K ﹤0.01% 1203
2025
Q1
$1.63M Buy
335,429
+250,236
+294% +$2.07M ﹤0.01% 1312
2024
Q4
$814K Sell
85,193
-59,003
-41% -$541K ﹤0.01% 1642
2024
Q3
$1.2M Buy
144,196
+12,670
+10% +$115K ﹤0.01% 1440
2024
Q2
$897K Buy
131,526
+14,360
+12% +$61.8K ﹤0.01% 1664
2024
Q1
$296K Buy
117,166
+3,500
+3% +$7.89K ﹤0.01% 2296
2023
Q4
$273K Buy
113,666
+3,595
+3% +$8.45K ﹤0.01% 2363
2023
Q3
$374K Buy
+110,071
New +$610K ﹤0.01% 2088
2021
Q2
Sell
-7,059
Closed -$656K 2731
2021
Q1
$656K Buy
7,059
+1,745
+33% +$179K ﹤0.01% 1827
2020
Q4
$476K Buy
5,314
+1,188
+29% +$109K ﹤0.01% 1872
2020
Q3
$426K Buy
+4,126
New +$445K ﹤0.01% 1806

Other funds holding EBS